Navigation Links
NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
Date:9/4/2007

dies of NGX-4010.

Dr. Jeffrey Tobias, Chief Medical Officer, commented, "We believe that NGX-4010 has the potential to provide an important therapeutic alternative to patients suffering from postherpetic neuralgia, a frequent, yet difficult to manage, neuropathic pain condition that can affect up to one in five shingles patients. We believe that a significant unmet medical need exists in the treatment of PHN, and that the results from this trial mark a significant step in our goal of providing an effective, peripherally-acting treatment option for this patient population."

Anthony DiTonno, Chief Executive Officer, said, "We believe that the results from this study are a significant validation of our efforts to develop our lead product candidate, NGX-4010, and for NeurogesX. These results represent a key milestone in our NGX-4010 development program. We feel that the consistency of both the magnitude and duration of effect of NGX-4010 is evidence of the potential benefits of this product candidate. With over 1,500 patients in our PHN and painful HIV-distal sensory polyneuropathy (HIV-DSP) clinical studies to date, we believe that we are building a significant body of evidence in support of a potential new drug application (NDA) filing in the second half of 2008."

NGX-4010 is a dermal patch designed to manage peripheral neuropathic pain. This is the second of two successful Phase 3 clinical trials of NGX-4010 for PHN that the Company has completed in the past year. The previously completed Phase 3 trial also demonstrated that a single, 60-minute treatment with NGX- 4010 applied directly to the site of pain may provide pain relief for up to 12 weeks.

In addition to being studied in PHN, NGX-4010 was also studied in a successful Phase 3 clinical trial in painful HIV-DSP and is currently being studied in a second Phase 3 trial for this indication which is currently in excess of 90% enrolled. Top-line results from this ongoing trial are expected in
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 16, 2014   HemCon Medical Technologies, Inc. ... TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and ... products, announced today that the revenue performance on ... percent, and microdispersed oxidized cellulose raw material is ... TWSI expects third quarter revenues to surpass the ...
(Date:9/16/2014)... On September 25 to 26, 2014, ... design and manufacturing - MEDTEC China  - will mark ... & Convention Center, bringing together close to 300 leading ... their latest medical-grade raw materials, parts and processing technologies. ... for free visitor pre-registration to be completed. To date, ...
(Date:9/16/2014)... Sept. 16, 2014 Based on its ... Frost & Sullivan recognises Incisive Surgical with the ... Value Leadership. Incisive Surgical,s uniquely-designed, innovative INSORB® Absorbable ... eliminates the need for patients to undergo the ... removal  that may result in increased pain, wound ...
Breaking Medicine Technology:HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 2HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 3HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 4MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 2Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 3Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 4Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 5
(Date:9/16/2014)... NY (PRWEB) September 16, 2014 Seven ... around the world will be honored in New York ... ( http://www.worldofchildren.org ), the only global recognition and funding ... , Hailed by the media as the “Nobel Prize ... have each created life-changing programs that benefit children in ...
(Date:9/16/2014)... Silver Spring, Md. (PRWEB) September 16, 2014 ... University of Colorado Anschutz Medical Campus and Children’s ... 2014. PHA is the country’s leading pulmonary hypertension association ... hypertension (PH) – a disease of the lungs that affects ... heart failure. Without treatment, mean survivability is only 2.8 years. ...
(Date:9/16/2014)... 2014 As part of its Latinos ... Citizens (LULAC) will host the second annual health festival ... feature free health screenings for osteoporosis, HIV, and high ... and cholesterol levels as well as bone marrow typing. ... under 6 years old , The event will also ...
(Date:9/16/2014)... -- Including women older than 70 in national breast ... in advanced forms of the disease, a new study ... could result in older women being overdiagnosed and overtreated, ... screen older women for breast cancer should be made ... using mass screening, the decision to participate in the ...
(Date:9/16/2014)... HealthDay Reporter TUESDAY, ... U.S. cancer survivors are alive today, compared to just ... Research reported Tuesday. These individuals amount to 4 ... of childhood cancer, according to the association,s annual progress ... and treatment of cancer and details some of the ...
Breaking Medicine News(10 mins):Health News:World of Children® Award Announces 2014 Honorees 2Health News:World of Children® Award Announces 2014 Honorees 3Health News:World of Children® Award Announces 2014 Honorees 4Health News:World of Children® Award Announces 2014 Honorees 5Health News:World of Children® Award Announces 2014 Honorees 6Health News:World of Children® Award Announces 2014 Honorees 7Health News:World of Children® Award Announces 2014 Honorees 8Health News:Help Fight Pulmonary Hypertension at the Colorado PH in the Park 2014 2Health News:LULAC Hosts Second Annual Latinos Living Healthy Feria de Salud in Los Angeles 2Health News:Some Benefits of Screening Elderly Women for Breast Cancer Questioned 2Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 2Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 3Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 4
... to country,s high rate of premature births , ... of infant mortality, the United States lags dismally behind ... high number of babies delivered prematurely, according to a ... 30th in the world in infant mortality," said Marian ...
... - Treating limited stage small cell lung cancer(LSCL) with ... shown encouraging results, opening the door to larger scale ... Texas M. D. Anderson Cancer Center. The Phase ... oral session at the annual meeting of the American ...
... ... videos as part of a new section on its website called "Baptist Medical News ... pediatric patients. As part the new portion of Baptist,s website to integrate video of ... , ...
... SHENZHEN, China, Nov. 3 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain,Drugstore ... the largest,drugstore chain in China based on the number of ... strategic cooperation agreement,with ATMU (China) Technology Co., Ltd., a subsidiary ... to install ATMs in Nepstar stores. , ...
... and tackling so-called neglected tropical diseases are the focus ... . The articles, by leading global health experts from ... dramatically, rising to meet them could save millions of ... with the current global economic slowdown, portends a drastic ...
... ... its services nationally through strengthening its outreach programs. , ... (PRWEB) November 3, 2009 -- ... preparatory school committed to experiential education and transformative therapeutics. The school embraces virtuous ...
Cached Medicine News:Health News:CDC Finds U.S. 30th in Infant Mortality 2Health News:CDC Finds U.S. 30th in Infant Mortality 3Health News:Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer 2Health News:Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer 3Health News:New Video Post Shows Minimally Invasive Procedure To Correct Sunken Chest Syndrome 2Health News:China Nepstar Enters Into Strategic Cooperation Agreement with ATMU to Install More Than 1,000 ATMs in Nepstar Stores 2Health News:China Nepstar Enters Into Strategic Cooperation Agreement with ATMU to Install More Than 1,000 ATMs in Nepstar Stores 3Health News:Global challenges and opportunities in fighting HIV/AIDS and neglected diseases 2Health News:Global challenges and opportunities in fighting HIV/AIDS and neglected diseases 3Health News:Global challenges and opportunities in fighting HIV/AIDS and neglected diseases 4Health News:Global challenges and opportunities in fighting HIV/AIDS and neglected diseases 5Health News:Therapeutic Boarding School to Provide Services Nationally 2
The Pinn-ACL Femoral Guide is offered in right and left versions and is designed to easily accommodate unusually large or small knees....
Hand surgery basic instrument set...
Needle holder, delicate, curved without lock...
Dilator...
Medicine Products: